Novo Nordisk's Wegovy gets UK approval for use to lower heart risks - Reuters.com
- Novo Nordisk's Wegovy gets UK approval for use to lower heart risks Reuters.com
- Weight-loss drug given green light to tackle heart problems BBC
- MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults GOV.UK
- Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment CNBC
- Millions more Brits could get weight-loss jabs on NHS to prevent heart attack and stroke – are you e... The Sun